Endocrine Medicine Topics Flashcards
describe the pathogenesis of T1DM
- autoimmune disease with unclear aetiology
- combination of genetic susceptibility (immune genes involved)
- and environmental triggers ( suggested to include viral infection and diet)
- Is a type IV hypersensitivity and autoimmune response with autoreactive T cells directed against Beta cells in the pancreatic islets
- results in progressive destruction of 80-90% of beta cells
- causes an absolute insulin deficiency → leads to hyperglycaemia
what are the typical signs and symptoms of T1DM? (6)
- secondary nocturnal enuresis (children)
- irritability
- classical triad of → polyuria, polydipsia and weight loss
- polyphagia
- fatigue and lethargy
- blurred vision
what are the typical signs and symptoms of diabetic ketoacidosis? (6)
- dehydration
- delirium or psychosis
- rapid breathing → kussmal in children
- abdominal pain
- nausea and vomiting
- ketonic fruity breath
what investigations to order to confirm diagnosis of T1DM? and what are the results of those tests?
- Random plasma glucose
- must be >11.1mmol/L
- Fasting plasma glucose
- must be > 7.0mmol/L
- 2- hour Oral Glucose Tolerance Test
- > 11.1mmol/L
- HbA1c
- > 6.5%
what additional tests can be ordered to distinguish between T1DM and T2DM?
- Islet autoantibodies
- present in type 1
- C-peptide levels -> indirect measure of insulin levels
- high suggests T2DM
- low suggests T1DM
What are the different modes of insulin delivery?
- Subcut delivery using needle or continuous pump
What is a typical insulin regime?
- basal insulin
- bolus insulin pre meal to account for cabohydrate levels
- supplemental insulin bolus to correct for abnormal BGL readings
What are the 5 key components in the long term management of a patient with T1DM?
Involvement of MDT
1. Patient education -> insulin dosing, diet, recognition and prevention of complications
2. Blood glucose monitoring -> goal 4-7mmol
3. Ketone monitoring -> when unwell or hyperglycaemic
4. HbA1c monitoring -> goal <7%
5 Diet
What is the pathogenesis of DKA?
Acute insulin deficiency
- Hyperglycaemia → osmotic diuresis → hypovolaemia and electrolyte derangement
- uninhibited lipolysis → increase in FFAs → increase in ketogenesis → ketosis and anion gap metabolic acidosis
what are the clinical features of DKA?
- classical diabetes triad
- polyuria
- polydipsia
- weight loss
- nausea and vomiting
- abdominal pain
- neurological changes
- altered consciousness
- lethargy
- coma
- Kussmaul breathing
- long deep breaths due to metabolic acidosis
- Fruity odour on breath from exhaled acetone
What is the diagnostic criteria of DKA?
- Hyperglycaemia
- BGL > 11mmol/L
- Ketosis
- presence of ketonemia or ketonuria
- Metabolic acidosis
- VBG:
- pH <7.3
- bicarbonate < 15mmol/L
- VBG:
Describe the 4 key steps in management of DKA
- ABCDE assessment including hydration status
- IV fluid rehydration
- normal saline used initially
- KCl added as potassium begins to drop
- 5% dextrose added when serum glucose begins to fall
- IV insulin infusion
- corrects hyperglycaemia, ketosis and acidosis
- Ongoing monitoring for complications
what can cause insulin induced hypoglycaemia?
- incorrect insulin dosage
- variation in diet
- cessation of hyperglycaemic drugs
- exercise
what are the two categories clinical features can be classed as?
- adrenergic
2. neuroglycopenic
what are the adrenergic symptoms of IIH?
- pale skin
- sweating
- shaking
- tremor
- palpitations
- anxiety
what are the neuroglycopenic symptoms of IIH?
- hunger
- confusion
- loss of consciousness
- seizures
What s the treatment of non-severe and severe IIH?
non-severe - oral fast acting glucose - oral fast acting carbs Severe - IV dextrose 10% - IM glucagon
what are some modifiable risk factors for T2DM?
- obesity
- physical inactivity
- poor diet
- stress
- smoking
what are non-modifiable risk factors for T2DM?
- increased age
- family history
- non-white ancestry
Describe the two main mechanisms behind the pathophysiology of T2DM
- Peripheral insulin resistance
- genetic and environmental factors result in impaired insulin dependent glucose uptake into the liver, muscle and fat tissue
- Pancreatic beta cell dysfunction
- initially the endocrine pancreas is capable of compensating for insulin resistance
- however, this capacity decreases over time as beta cells lose their secretory capacity
Briefly describe the progression to diabetes from normal physiology
normal → prediabetes with impaired glucose tolerance and isolated postprandial hyperglycaemia → diabetes with fasting hyperglycaemia
what are the signs of T2DM? (not chronic complications)
- poor wound healing
- recurrent infections
- signs of insulin resistance → acanthosis nigracans, skin tags and hirsutism
what are some symptoms of T2Diabetes (not chronic complications)
- polyuria
- polydipsia
- lethargy
- blurred vision
- loss of sensation
what are the 4 key tests used to diagnose T2DM?
- Random plasma glucose
- must be >11.1mmol/L
- Fasting plasma glucose
- must be > 7.0mmol/L
- 2- hour Oral Glucose Tolerance Test
- > 11.1mmol/L
- HbA1c
- > 6.5%
What investigations should be ordered for monitoring of diabetes?
- HbA1c
- Lipids
- LDL-c, HDL-c, total cholesterol, Triglycerides
- UECs
- eGFR → monitoring nephropathy
- UA
- looking for glycosuria
- proteinuria as assessment of kidney function and or damage.
Who is on the MDT for a person with T2DM?
- GP
- Diabetes educator
- nutritionist/dietitian
- Podiatrist
- exercise physiologist
What lifestyle changes are advisable for a person with T2DM?
- increasing level of physical activity
- weight loss and improving insulin sensitivity
- weight loss → aggressive → bariatric surgery an option
- smoking cessation
- alcohol reduction
- balanced nutritious diet
What are the BGLs to aim for in a person with T2DM?
aim to keep BGLs between 4-7mmol fasting and 5-10mmol postprandial
what is the first line drug for hyperglycaemic control?
metformin
what drugs are second and third line?
- sulfonylureas → glicazide
- SGLT2 inhibitors → dapagliflozin
- DPP-4 inhibitors → sitaglipitin
what drugs are 4th line?
- TZDs → pioglitazone
- acarbose
- GLP-1 analogue → exenatide, liraglutide
- Insulin
what are the three main classes of drugs for diabetes and their brief MOA?
- Sensitiers → increase tissue sensitivity to insulin
- Increasers → drugs that increase insulin
- Decreasers → drugs that lower Glucose
What is the MOA of sensitiers for Diabetes?
- improve tissue response to insulin
2. improves tissue utilisation of glucose, decreases liver production of glucose
What is the MOA of Increasers for Diabetes?
- they act via various mechanisms to increase amount of insulin circulating
What are the 4 types of increasers?
- sulfonureas
- GLP-1 analgue
- DPP-4 inhibitors
- Insulin
What is the mechanism of action of Sulfonureas?
- stimulate release of insulin from the pancreas
What are examples of sulfonureas?
- Gliclazide
- glibenclamide
- glipizide
- glimepiride
What are some examples of GLP-1 analogues?
- Glutides*
1. dulaglutide
2. exenatide
3. liraglutide
4. semaglutide